Binx Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 106

Employees

  • Latest Deal Type
  • Series F

  • Latest Deal Amount
  • $82.5M

  • Investors
  • 19

Binx General Information

Description

Developer of a point-of-care testing platform designed to improve the well-being of communities by providing pathways to care that prioritizes clinical integrity and patient convenience. The company's platform offers rapid polymerase chain reaction (PCR)-based results as well as provides a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up to increase screening and reduce infections, enabling people to get accurate diagnostic reports through discreet testing.

Contact Information

Website
mybinxhealth.com
Formerly Known As
Atlas Genetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 245 First Street, Riverview II
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (844)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Vertical(s)
LOHAS & Wellness, Digital Health, SaaS, TMT, HealthTech
Corporate Office
  • 245 First Street, Riverview II
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (844)

Binx Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Binx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC (Series F) 05-Apr-2024 $82.5M Completed Generating Revenue
16. Secondary Transaction - Private 26-Apr-2022 Completed Generating Revenue
15. Later Stage VC (Series E) 27-May-2021 Completed Generating Revenue
14. Secondary Transaction - Private 05-Jan-2018 Completed Generating Revenue
13. Grant 14-Aug-2017 Completed Generating Revenue
12. Later Stage VC (Series D) 23-Jan-2017 Completed Generating Revenue
11. Grant Completed Generating Revenue
10. Grant 15-Mar-2016 Completed Generating Revenue
9. Later Stage VC (Series C) 29-Jan-2015 $19.6M $57.1M Completed Generating Revenue
8. Later Stage VC (Series B) 29-Apr-2014 $29.3M $37.5M Completed Generating Revenue
To view Binx’s complete valuation and funding history, request access »

Binx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series F
Series E
Series E
Series E
Series D
Series C
EIS
EIS
Series B 94,979 $0.012698 $126.98 $126.98 1x $126.98 9.15%
Series B 62,704 $0.012698 $158.73 $158.73 1x $158.73 6.04%
To view Binx’s complete cap table history, request access »

Binx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a point-of-care testing platform designed to improve the well-being of communities by providing pathways to
Diagnostic Equipment
Cambridge, MA
106 As of 2023

Lausanne, Switzerland
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Binx Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abionic Venture Capital-Backed Lausanne, Switzerland
ChipCare Venture Capital-Backed Toronto, Canada
miDiagnostics Venture Capital-Backed Leuven, Belgium
myLABBox Venture Capital-Backed Los Angeles, CA
Nanomix Formerly VC-backed San Leandro, CA
You’re viewing 5 of 8 competitors. Get the full list »

Binx Patents

  • 207

    Total Documents Applications and Grants

  • Total Patents Families

  • 126

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

Binx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230402168-A1 Medical systems and methods Pending 14-Jun-2022
US-20220165423-A1 Systems and methods for diagnostic testing Pending 25-Nov-2020
CA-3203143-A1 Systems and methods for diagnostic testing Pending 25-Nov-2020
EP-4252244-A1 Systems and methods for diagnostic testing Pending 25-Nov-2020
US-20200185071-A1 Facilitating sexually transmitted infection services Pending 10-Dec-2018 G06F21/6245
To view Binx’s complete patent history, request access »

Binx Executive Team (23)

Name Title Board Seat
Jeffrey Luber JD Chief Executive Officer and Board Member
Jack Crowley Chief Financial Officer
Anna Dixon Ph.D Chief Operating Officer & Chief Technology Officer
Michael Karsonovich Chief Commercial Officer
Pia Olson Senior Vice President of Human Resources & Board Member
You’re viewing 5 of 23 executive team members. Get the full list »

Binx Board Members (33)

Name Representing Role Since
Alex Kramer Binx Vice President of Digital Product and Technology & Board Member
Andrew Goldman Self Board Member
David Hwang Self Board Member
Elizabeth Mora Self Board Member
Gail Marcus Self Board Member
You’re viewing 5 of 33 board members. Get the full list »

Binx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Binx Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Life Sciences Venture Capital Minority
ArrowMark Partners Asset Manager Minority
Hildred Capital Partners Family Office Minority
OrbiMed Growth/Expansion Minority
Parian Global Management Hedge Fund Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Binx FAQs

  • When was Binx founded?

    Binx was founded in 2005.

  • Who is the founder of Binx?

    John Clarkson Ph.D and Pavel Rodyukov are the founders of Binx.

  • Who is the CEO of Binx?

    Jeffrey Luber JD is the CEO of Binx.

  • Where is Binx headquartered?

    Binx is headquartered in Cambridge, MA.

  • What is the size of Binx?

    Binx has 106 total employees.

  • What industry is Binx in?

    Binx’s primary industry is Diagnostic Equipment.

  • Is Binx a private or public company?

    Binx is a Private company.

  • What is Binx’s current revenue?

    The current revenue for Binx is .

  • How much funding has Binx raised over time?

    Binx has raised $280M.

  • Who are Binx’s investors?

    Alta Life Sciences, ArrowMark Partners, Hildred Capital Partners, OrbiMed, and Parian Global Management are 5 of 19 investors who have invested in Binx.

  • Who are Binx’s competitors?

    Abionic, ChipCare, miDiagnostics, myLABBox, and Nanomix are some of the 8 competitors of Binx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »